CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation Q1 FY2024 earnings call
July 10, 2023 · fiscal period ended 2024-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2023-07-10
Management highlights
Management Statement and Operational Highlights
- Strategic Initiatives: Converted installed base to subscription-model, focused sales on full stack solutions, set up customer success team, and restructured for improved cash flow and profitability.
- Q1 Financials: Recognized $70.9 million in revenue. Gross margin grew 280 basis points to 38%, adjusted EBITDA was $6 million. Operating expenses reduced by $5.4 million year-over-year due to cost efficiencies.
- Sales Efforts: Dedicated bandwidth to new logo generation, closed deals with new enterprise fleet customers (e.g., R&L carriers with 18,000 subscribers), and new product Vision 2.0 dash camera driving bookings.
- Compensation Programs: Rolled out new sales compensation programs aligning with growth goals.
- International: Consumer, automotive business performing well, with operating models aligned under a single leader for cost efficiency.
Segment performance
Segment Performance
- Large Industrial Customers: Generated approximately $16.6 million in revenue in Q1, with this performance expected to continue.
- Telematics Service Providers (TSPs) and Channel Customers: Experienced demand softness as they adjusted order volumes and inventory strategies due to normalized shipping environment.
- Consumer, Automotive Business: Performed well in Q1 with profitable growth, expecting to ramp up revenues from the BMW relationship.
- Recurring Application Subscription Revenue: Saw modest sequential growth of ~$100,000, with net subscribers increasing 6% sequentially to 1.69 million.
Guidance
Guidance
- Q2 FY 2024: Revenue expected to range $67 million - $73 million, adjusted EBITDA $5 million - $9 million.
- Long-Term: Aim for EBITDA margins in mid-teens via normalization of telematic device revenues, recurring revenue growth from new solutions, and aggressive cost reductions.
Risks
Risks
- Strategic Alternatives: Board engaged advisors to explore strategic alternatives, but no specific risks detailed.
- Inventory Normalization: TSPs and channel customers adjusting inventory levels, taking a few quarters to correct.
- Convertible Note: $230 million 2% convertible senior notes due 2025, requiring various financing options to resolve.
Q&A highlights
Question and Answer
Q: Clarification on inbound inquiries and inventory levels/gross margin guidance A: Plural inbound inquiries; inventory normalization expected in Q3/Q4; gross margin expected to trend towards historical 40% levels with shift to full stack solutions.
Q: Free cash flow positive and deferred revenue A: Free cash flow expected to turn positive over several quarters; deferred revenue decline due to K-12 seasonality.
Q: Recurring application subscriptions and K-12 business A: Recurring subscriptions up sequentially but down year-on-year due to low ARPU from TSP conversions; K-12 business softness due to seasonality, expected to bounce back.
Q: Competitive landscape and share A: TSP business unique, customers value configurability despite higher pricing; focus on full stack customers and recurring revenue to compete with peers like Geotab and Samsara.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $-0.23 | $0.92 | -125.0% | $-2.30 |
| Revenue | $70.9M | $70.3M | +0.8% | $68.4M |
Transcript
July 10, 2023Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.